Drug Recall – Avandia


Avandia, the type-2 diabetes medication, has had its use severely restricted in the United States, and the drug has been withdrawn from the market in Europe due to concerns over severe side effects. The U.S. Food and Drug Administration (FDA) concluded there is significant evidence that Avandia, also known as rosiglitazone, increases the risk of heart attack, stroke, and congestive heart failure in those taking it.

Comments are closed.